gusperimus has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booser, D; Buzdar, A; Dhingra, K; Fraschini, G; Gutierrez, L; Holmes, F; Hortobagyi, G; Theriault, R; Valero, V | 1 |
| Booser, D; Buzdar, A; Dhingra, K; Fritsche, H; Greene, D; Kelley, S; Khazaeli, MB; LoBuglio, AF; Murray, JL; Tepper, M | 1 |
2 trial(s) available for gusperimus and Neoplasm Metastasis
| Article | Year |
|---|---|
Phase II study of deoxyspergualin in metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Breast Neoplasms; CD4-CD8 Ratio; Female; Guanidines; Humans; Hypotension; Magnesium; Middle Aged; Neoplasm Metastasis; Neuromuscular Diseases | 1994 |
Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study.
Topics: Adult; Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Formation; Female; Guanidines; Humans; Immunosuppressive Agents; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasms; Recombinant Fusion Proteins; Species Specificity | 1994 |